In a key decision, the Centers for Medicare and Medicaid Services (CMS) said today that Medicare will not pay for the controversial Alzheimer’s drug Adulhelm until it sees positive results from a government-approved trial.
Subscribe to:
Post Comments (Atom)
< + > PerfectServe Uses AI to Transform Healthcare Workflow Orchestration
After 30 years of orchestrating workflows and connecting systems across providers and IT vendors, PerfectServe continues to expand what it ...
No comments:
Post a Comment